Randomization procedure with gender strati­fication [Design Issues]

posted by Silva – Portugal, 2014-02-26 13:27 (4070 d 01:59 ago) – Posting: # 12502
Views: 6,678

Dear all

Does it make any sense covering in the randomization procedure in SAS, gender stratification for BE studies? Despite FDA refers that BE study data is not expected to have sufficient power to draw conclusions for each subgroup and therefore statistical analysis of subgroups is not recommended, do you think in a near future this may overcome?

Best regards
Silva

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,699 registered users;
27 visitors (0 registered, 27 guests [including 6 identified bots]).
Forum time: 16:26 CEST (Europe/Vienna)

Do not put your faith in what statistics say until you have carefully
considered what they do not say.    William W. Watt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5